Bladder Cancer Global Clinical Trials Review, H1, 2014
Bladder Cancer Global Clinical Trials Review, H1, 2014
Summary
Glob...
glaxosmithkline Plc 41
clinical Trial Overview Of Glaxosmithkline Plc 41
eli Lilly And Company 43
clinical Trial Overview ...
Bladder Cancer Global Clinical Trials Review, H1, 2014
Upcoming SlideShare
Loading in...5
×

Bladder cancer global clinical trials review, h1, 2014

108

Published on

Published in: Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
108
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
0
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Bladder cancer global clinical trials review, h1, 2014

  1. 1. Bladder Cancer Global Clinical Trials Review, H1, 2014 Bladder Cancer Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, Bladder Cancer Global Clinical Trials Review, H1, 2014" provides data on the Bladder Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bladder Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Bladder Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Reasons to buy - Understand the dynamics of a particular indication in a condensed manner - Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more - Obtain discontinued trial listing for trials across the globe - Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies Table Of Contents table Of Contents 2 list Of Tables 4 list Of Figures 5 introduction 6 bladder Cancer 6 report Guidance 6 clinical Trials By Region 7 clinical Trials And Average Enrollment By Country 8 top Five Countries Contributing To Clinical Trials In Asia-pacific 10 top Five Countries Contributing To Clinical Trials In Europe 11 top Countries Contributing To Clinical Trials In North America 12 top Countries Contributing To Clinical Trials In Middle East And Africa 13 top Countries Contributing To Clinical Trials In Central And South America 14 clinical Trials By G7 Countries: Proportion Of Bladder Cancer To Oncology Clinical Trials 15 clinical Trials By Phase In G7 Countries 16 clinical Trials In G7 Countries By Trial Status 17 clinical Trials By E7 Countries: Proportion Of Bladder Cancer To Oncology Clinical Trials 18 clinical Trials By Phase In E7 Countries 19 clinical Trials In E7 Countries By Trial Status 20 clinical Trials By Phase 21 in Progress Trials By Phase 22 clinical Trials By Trial Status 23 clinical Trials By End Point Status 24 unaccomplished Trials Of Bladder Cancer 25 subjects Recruited Over A Period Of Time 32 clinical Trials By Sponsor Type 33 prominent Sponsors 34 top Companies Participating In Bladder Cancer Therapeutics Clinical Trials 35 prominent Drugs 37 latest Clinical Trials News On Bladder Cancer 38 jan 13, 2014: Tengion Announces Continued Clinical Progress In Its Neo-urinary Conduit Program 38 dec 30, 2013: Heat Biologics Announces Its Phase 1/2 Study Of Hs-410 In Bladder Cancer Is Open For Enrollment 38 nov 25, 2013: Heat Biologics Successfully Completes Manufacturing Of Hs-410 To Start Phase 1/2 Bladder Cancer Trial 39 jul 16, 2013: Oncogenex Announces Completion Of Patient Enrollment In The Borealis-1 Trial Of Ogx-427 In Metastatic Bladder Cancer 39 apr 30, 2013: Oncogenex Pharma Initiates Phase Ii Bladder Cancer Trial Of Ogx-427 In Combination With Docetaxel 40 clinical Trial Profiles 41 clinical Trial Overview Of Top Companies 41 Bladder Cancer Global Clinical Trials Review, H1, 2014
  2. 2. glaxosmithkline Plc 41 clinical Trial Overview Of Glaxosmithkline Plc 41 eli Lilly And Company 43 clinical Trial Overview Of Eli Lilly And Company 43 pfizer Inc. 44 clinical Trial Overview Of Pfizer Inc. 44 spectrum Pharmaceuticals, Inc. 45 clinical Trial Overview Of Spectrum Pharmaceuticals, Inc. 45 sanofi 46 clinical Trial Overview Of Sanofi 46 merck & Co., Inc. 47 clinical Trial Overview Of Merck & Co., Inc. 47 bayer Ag 48 clinical Trial Overview Of Bayer Ag 48 f. Hoffmann-la Roche Ltd. 49 clinical Trial Overview Of F. Hoffmann-la Roche Ltd. 49 endo Health Solutions Inc. 50 clinical Trial Overview Of Endo Health Solutions Inc. 50 bristol-myers Squibb Company 51 clinical Trial Overview Of Bristol-myers Squibb Company 51 clinical Trial Overview Of Top Institutes / Government 52 national Cancer Institute 52 clinical Trial Overview Of National Cancer Institute 52 memorial Sloan Kettering Cancer Center 60 clinical Trial Overview Of Memorial Sloan Kettering Cancer Center 60 european Organization For Research And Treatment Of Cancer 63 clinical Trial Overview Of European Organization For Research And Treatment Of Cancer 63 the University Of Texas M. D. Anderson Cancer Center 65 clinical Trial Overview Of The University Of Texas M. D. Anderson Cancer Center 65 national Bladder Cancer Collaborative Group 67 clinical Trial Overview Of National Bladder Cancer Collaborative Group 67 southwest Oncology Group 69 clinical Trial Overview Of Southwest Oncology Group 69 medical Research Council Clinical Trials Unit 70 clinical Trial Overview Of Medical Research Council Clinical Trials Unit 70 university Of Michigan 71 clinical Trial Overview Of University Of Michigan 71 eastern Cooperative Oncology Group 72 clinical Trial Overview Of Eastern Cooperative Oncology Group 72 medical Research Council 73 clinical Trial Overview Of Medical Research Council 73 five Key Clinical Profiles 74 appendix 134 abbreviations 134 definitions 134 research Methodology 135 secondary Research 135 about Globaldata 136 contact Us 136 disclaimer 136 source 137 ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price. Contact: M/s Sheela, 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-997-4948 Email: sales@researchmoz.us Website: http://www.researchmoz.us/ Bladder Cancer Global Clinical Trials Review, H1, 2014
  3. 3. Bladder Cancer Global Clinical Trials Review, H1, 2014

×